Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review

Vitaloni, Marianna; Botto-van Bemden, Angie; Sciortino Contreras, Rosa Maya; Scotton, Deborah; Bibas, Marco; Quintero, Maritza; Monfort, Jordi; Carné, Xavier; de Abajo, Francisco; Oswald, Elizabeth; Cabot, Maria R.; Matucci, Marco; du Souich, Patrick; Möller, Ingrid; Eakin, Guy; Verges, Josep

doi:10.1186/s12891-019-2895-3

Table 1 Overview of studies reporting QoL in patients with KOA

From: Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review

References	Country	Study design	QoL instrument	Total Sample Size	Control Population	KOA Patients	Mean age	Gender Distribution
Cuzdan, 2017 [11]	Turkey	Cross-Sectional	SF-36	85	25	60	65.79	Knee OA: 57 female; 3 male
Cuzdan, 2017 [11]	Turkey	Cross-Sectional	SF-36	85	25	60	65.79	Control: 13 female; 12 male
Elbaz, 2017 [12]	Israel	Prospective observational	SF-36	93	30	63	64.2	Knee OA: 41 female; 22 male
Elbaz, 2017 [12]	Israel	Prospective observational	SF-36	93	30	63	64.2	Control: 9 female; 21 male
Lee, 2017 [13]	USA	Cross-Sectional	SF-36	120	40	80	60.3	Knee OA: 61 female; 19 male
Lee, 2017 [13]	USA	Cross-Sectional	SF-36	120	40	80	60.3	Control: NA
Rundell, 2017 [14]	USA	Prospective	EQ-5D	5155	4711	368	75.3	Knee OA: 272 female; 96 male
Rundell, 2017 [14]	USA	Prospective	EQ-5D	5155	4711	368	75.3	Control 3017 female; 1694 male
Wright, 2017 [15]	Australia	Cross-Sectional	SF-36	120	40	80	64	Knee OA: 44 female; 36 male
Araujo, 2016 [16]	Brazil	Cross-Sectional	SF-12	93		93	60	Knee OA: 69 female; 24 male Control: 24 female; 16 male
Bokaeian, 2016 [17]	Iran	Randomized clinical trial	WOMAC	28		28	52.9	Knee OA: 25 female; 2 male
Cho, 2016 [18]	Republic of Korea	Prospective cohort study	SF-36	681			71.9	Knee OA: 383 female; 298 male
Kaban, 2016 [19]	Turkey	Cross-Sectional	SF-36	63	21	42	56.86	All female
Gomes-Neto, 2016 [20]	Brazil	Cross-Sectional	SF-36	35		35	66.57	Knee OA: 29 female; 6 male
Khatib, 2016 [21]	Australia	Cross-Sectional	Tot. EQ (adjusted from EQ-5D-5L)	2809		2809	68	Knee OA: 1740 female; 1069 male
Kiadaliri, 2016 [22]	Sweden	Population based cohort study	EQ-5D	1501	744	402	71.5	Group 1 (reference group having neither knee pain nor radiographic or clinically-defined knee OA) 469 female; 275 male
								Group 2 (knee pain with-out OA) 119 female; 50 male
								Group 3 (kne epain with OA) 256 female; 146 male
Kiadaliri, 2016 [23]^a	Sweden	Retrospective	EQ-5D	First stage 7402; Second stage 1527		The number of people diagnosis with knee OA is not specified	69.4	First stage 4604 female; 2798 male
Kiadaliri, 2016 [23]^a	Sweden	Retrospective	EQ-5D	First stage 7402; Second stage 1527			69.4	Second stage 977 female; 550 male
Oishi, 2016 [24]	Japan	Cross-Sectional	KOOS	963		397	54.33	Total: 595 female; 368 male
Oishi, 2016 [24]	Japan	Cross-Sectional	KOOS	963		397	54.33	Knee OA: 299 female; 98 male
Sarumathy, 2016 [25]	India	Prospective study	SF-36	74		74	51.7	Knee OA: 55 female; 19 male
Cavalcante, 2015 [26]	Brazil	Cross-Sectional	WHOQOL	90	40	50	67	All female
Fang, 2015 [27]	Taiwan	Population based study	SF-12	901	441	460	74.04	Total: 492 female; 409 male
Fang, 2015 [27]	Taiwan	Population based study	SF-12	901	441	460	74.04	Knee OA: 232 female; 209 male
Ferreira, 2015 [28]	Brazil	Cross-Sectional	SF-36	75	35	40	68.36	All female
Kawano, 2015 [29]	Brazil	Cross-Sectional	SF-36	93		93	61.2	Knee OA: 69 females; 24 male
Kim, 2015 [30]	Korea	Cross-Sectional	EQ-5D	2165		2165	67.73	Knee OA: 1458 female; 707 male
Lee, 2015 [31]	South Korea	Cross-Sectional	EQ-5D	7977		7977	61.5	Knee OA: 5448 female; 4064 male
Pang, 2015 [32]	China	Cross-Sectional	SF-36	466		466	56.56	Knee OA: 382 female; 84 male
Rakel, 2015 [33]	USA	Cross-Sectional	SF-36	100	25	75	56	Knee OA: 46 female; 29 male
Rakel, 2015 [33]	USA	Cross-Sectional	SF-36	100	25	75	56	Control: 15 female; 10 male
Reid, 2015 [34]	USA	Randomized controlled trial	SF-36	190		190	60.2	Knee OA: 132 female; 58 male
Tsonga, 2015 [35]	Greece	Longitudinal	SF-36	68		68	73	Knee OA: 57 female; 11 male
Visser, 2015 [36]	Netherlands	Cross-Sectional	SF-36	1262	1060	205	56	Total: 707 female; 578 male
								Knee OA: 125 female; 80 male
								Control: 583 female; 477 male
Alburquerque-garcía, 2015 [37]	Spain	Cross-Sectional	SF-36	36	18	18	85	All female
Alkan, 2014 [38]	Turkey	Cross-Sectional	SF-36	152	40	112	60	Knee OA: 85 female; 27 male
Alkan, 2014 [38]	Turkey	Cross-Sectional	SF-36	152	40	112	60	Control: 30 female 10 male
Forkel, 2014 [39]	Germany	Cross-Sectional	KOOS	22		22	47	Knee OA: 17 female; 6 male
Jahnke, 2014 [40]	Germany	Cross-Sectional	HAS	159		159	63.5	Knee OA: 75 female; 84 male
Marks, 2014 [41]	USA	Cross-Sectional	AIMS	21		21	70.8	All female
Pérez-Prieto, 2014 [42]	Spain	Prospective cohort study	SF-36	716		716	72	Knee OA: 421 female; 295 male
Reis, 2014 [43]	Brazil	Cross-Sectional	WHOQOL	12		12	67.25	All female
Alentorn, 2013 [44]	Spain	Cross-Sectional	SF-36	391		391	70.7	Knee OA: 303 female; 89 male
Clement, 2013 [45]	UK	Cross-Sectional	SF-12	996		996	70.32	Knee OA: 545 female; 421 male
Vulcano, 2013 [46]	USA	Prospective cohort study	SF-36	4732		4732	66.88	Knee OA: 2881 female; 1851 male
Williams, 2013 [47]	UK	Cross-Sectional	EQ-5D	2456		2456	71.4	Knee OA: 1494 female; 962 male
Coleman, 2012 [48]	Australia	Cross-Sectional	SF-36	146		146	65	Knee OA: 109 female; 37 male
Gonçalves, 2012 [49]	Portugal	Cross-Sectional	SF-36	136		136	67.2	Knee OA: 94 female; 42 male
Lim, 2012 [50]	Philippine	Cross-Sectional	WOMAC	90			70.14	Knee OA: 68 female; 22 male
Elbaz, 2011 [51]	Israel	Cross-Sectional	SF-36	1487		1487	61.9	Knee OA: 950 female; 537 male
Gonçalves, 2011 [52]	Portugal	Cross-Sectional	KOOS	377		377	67.8	Knee OA: 282 females; 95 males
Norimatsu, 2011 [53]	Japan	Prospective population-based cohort study	Japanese Knee Osteoarthritis Measure (JKOM)	333		333	64.2	All female
Ozcakir, 2011 [54]	Turkey	Cross-Sectional	NHP	100		100	59.5	Knee OA: 83 female; 17 male
Paker, 2011 [55]	Turkey	Cross-Sectional	SF-36	75		75	66.1	All female
Foroughi, 2010 [56]	Australia	Cross-Sectional	SF-36	17		17	66	All female
Jenkins, 2010 [57]	USA	Cross-Sectional	QLI-A	75		75	69	Knee OA: 57 female; 18 male
Kim, 2010 [58]	Korea	Prospective cohort study	WOMAC	504		504	70.2	Knee OA: 274 female; 230 male
Muraki, 2010 [59]	Japan	Cross-Sectional	SF-8	2126		2126	68.9	Knee OA: 1359 female; 767 male
Watanabe, 2010 [60]	Japan	Cross-Sectional	Japanese Knee Osteoarthritis Measure (JKOM)	18		18	67	All female
Yildiz, 2010 [61]	Turkey	Cross-Sectional	NHP	140		140	59.39	Knee OA: 104 females; 36 males
Debi, 2009 [62]	Israel	Cross-Sectional	SF-36	134			66.95	Knee OA: 85 females; 49 males
Imamura, 2008 [63]	Brazil	Cross-Sectional	SF-36	84	22	62	71.1	All female
Imamura, 2008 [63]	Brazil	Cross-Sectional	SF-36	84	22	62	Control 68.95	All female
Liikavainio, 2008 [64]	Finland	Cross-Sectional	RAND-36	107	53	54	59	All male
Liikavainio, 2008 [64]	Finland	Cross-Sectional	RAND-36	107	53	54	Control 59.24	All male
Wang, 2008 [65]	Germany	Cross-Sectional	SF-36	1009		1009	48.5	Knee OA: 620 female; 389 male
Nunez, 2007 [66]	Spain	Cross-Sectional	SF-36	100		100	71.2	Knee OA: 71 female; 29 male
Salaffi, 2005 [67]	Italy	Cross-Sectional	SF-36	264		KneeOA 108	65.7	Knee OA: 64 female; 44 male
Salaffi, 2005 [67]	Italy	Cross-Sectional	SF-36	264		Knee OA + Hip OA 51	65.7	Knee OA + Hip OA: 32 female; 19 male
Chacón, 2004 [68]	Venezuela	Cross-Sectional	AIMS	126		126	64	Knee OA: 106 female; 20 male
Lam, 2000 [69]	China	Cross-Sectional case–control study	COOP/WONCA	760		760	57.6	Knee OA: 538 female; 222 male
de Leeuw, 1998 [70]	UK	Prospective trial	Rosser Index Matrix	101		101	71.5	Knee OA: 62 female; 39 male
Donnell, 1998 [71]	France	Cross-Sectional	Rosser Index Matrix	221		221	No specified	Knee OA: 174 female; 47 male
Ries, 1995 [72]	USA	Cross-Sectional	AIMS	47		47	69.2	Knee OA: 44 female; 3 male

SF-36/SF-12/SF-8 (n=34); EQ-5D (n=6); KOOS (n=3); AIMS(n=3); WOMAC(n=3); Rossser Index matrix (n=2); NHP (n=2);JKOM(n=2); WHOQOL(n=2);COOP/WONCA (n=1); HAS(n=1); RAND-36(n=1)
^aNot possible to add this article in gender calculation

Back to article page

ISSN: 1471-2474

Contact us

Submission enquiries: bmcmusculoskeletaldisorders@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Musculoskeletal Disorders

Contact us